Inhibition of TGFBIp expression reduces lymphangiogenesis and tumor metastasis

Oncogene

Volumn 35, Issue 2, 2016, Pages 196-205

  Maeng, Y S ^a   Aguilar, B ^b   Choi, S I ^a   Kim, E K ^a  

^a Yonsei University College of Medicine   (South Korea)

^b SECTION OF CELL AND DEVELOPMENTAL BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; FOCAL ADHESION KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; SCLEROPROTEIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR FKHR; TRANSFORMING GROWTH FACTOR BETA INDUCED PROTEIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; BETAIG-H3 PROTEIN; CADHERIN; CCL21 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL ACTIVATION; CELL ADHESION; CELL DIFFERENTIATION; CELL JUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURFACE; COLON CANCER; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; INTRACELLULAR SIGNALING; LYMPHANGIOGENESIS; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; ONCOGENE SRC; PERMEABILITY; PHOTOSYNTHETIC PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VOLUME; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL MOTION; DRUG SCREENING; ENDOTHELIUM CELL; GENETICS; LYMPH NODE METASTASIS; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; CADHERINS; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL21; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MICE, INBRED NOD; PERMEABILITY; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSFORMING GROWTH FACTOR BETA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84955132643     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.73     Document Type: Article

References (35)

1. Fidler IJ, Balch CM. The biology of cancer metastasis and implications for therapy. Curr Probl Surg 1987; 24: 129-209.
2. Sporn MB. The war on cancer. Lancet 1996; 347: 1377-1381.
3. Stacker SA, Baldwin ME, Achen MG. The role of tumor lymphangiogenesis in metastatic spread. FASEB J 2002; 16: 922-934.
4. Sleeman JP, Thiele W. Tumor metastasis and the lymphatic vasculature. Int J Cancer 2009; 125: 2747-2756.
5. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001; 49: 507-521.
6. Thapa N, Lee BH, Kim IS. TGFBIp/betaig-h3 protein: a versatile matrix molecule induced by TGF-beta. Int J Biochem Cell Biol 2007; 39: 2183-2194.
7. Park SW, Bae JS, Kim KS, Park SH, Lee BH, Choi JY et al. Beta ig-h3 promotes renal proximal tubular epithelial cell adhesion, migration and proliferation through the interaction with alpha3beta1 integrin. Exp Mol Med 2004; 36: 211-219.
8. Kim YH, Kwon HJ, Kim DS. Matrix metalloproteinase 9 (MMP-9)-dependent processing of betaig-h3 protein regulates cell migration, invasion, and adhesion. J Biol Chem 2012; 287: 38957-38969.
9. Skonier J, Bennett K, Rothwell V, Kosowski S, Plowman G, Wallace P et al. beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 1994; 13: 571-584.
10. Kim JE, Kim EH, Han EH, Park RW, Park IH, Jun SH et al. A TGF-beta-inducible cell adhesion molecule, betaig-h3, is downregulated in melorheostosis and involved in osteogenesis. J Cell Biochem 2000; 77: 169-178.
11. Bae JS, Lee SH, Kim JE, Choi JY, Park RW, Yong Park J et al. Betaig-h3 supports keratinocyte adhesion, migration, and proliferation through alpha3beta1 integrin. Biochem Biophys Res Commun 2002; 294: 940-948.
12. Kim JE, Kim SJ, Jeong HW, Lee BH, Choi JY, Park RW et al. RGD peptides released from beta ig-h3, a TGF-beta-induced cell-adhesive molecule, mediate apoptosis. Oncogene 2003; 22: 2045-2053.
13. Zhang Y, Wen G, Shao G, Wang C, Lin C, Fang H et al. TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer Res 2009; 69: 37-44.
14. Becker J, Erdlenbruch B, Noskova I, Schramm A, Aumailley M, Schorderet DF et al. Keratoepithelin suppresses the progression of experimental human neuroblastomas. Cancer Res 2006; 66: 5314-5321.
15. Ween MP, Oehler MK, Ricciardelli C. Transforming growth factor-beta-induced protein (TGFBI)/(betaig-H3): a matrix protein with dual functions in ovarian cancer. Int J Mol Sci 2012; 13: 10461-10477.
16. Nam JO, Kim JE, Jeong HW, Lee SJ, Lee BH, Choi JY et al. Identification of the alphavbeta3 integrin-interacting motif of betaig-h3 and its anti-angiogenic effect. J Biol Chem 2003; 278: 25902-25909.
17. Irigoyen M, Anso E, Salvo E, Dotor de las Herrerias J, Martinez-Irujo JJ, Rouzaut A. TGFbeta-induced protein mediates lymphatic endothelial cell adhesion to the extracellular matrix under low oxygen conditions. Cell Mol Life Sci 2008; 65: 2244-2255.
18. Lee AS, Kim DH, Lee JE, Jung YJ, Kang KP, Lee S et al. Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis. Cancer Res 2011; 71: 4506-4517.
19. Christiansen A, Detmar M. Lymphangiogenesis and cancer. Genes Cancer 2011; 2: 1146-1158.
20. Albrecht I, Christofori G. Molecular mechanisms of lymphangiogenesis in development and cancer. Int J Dev Biol 2011; 55: 483-494.
21. Miyagaki T, Sugaya M, Okochi H, Asano Y, Tada Y, Kadono T et al. Blocking MAPK signaling downregulates CCL21 in lymphatic endothelial cells and impairs contact hypersensitivity responses. J Invest Dermatol 2011; 131: 1927-1935.
22. Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 2007; 204: 2349-2362.
23. Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VEcadherin in the control of vascular permeability. J Cell Sci 2008; 121: 2115-2122.
24. Hewitt RE, McMarlin A, Kleiner D, Wersto R, Martin P, Tsokos M et al. Validation of a model of colon cancer progression. J Pathol 2000; 192: 446-454.
25. Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG. Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 2007; 96: 1092-1100.
26. Schoppmann SF, Fenzl A, Nagy K, Unger S, Bayer G, Geleff S et al. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery 2006; 139: 839-846.
27. Wartiovaara U, Salven P, Mikkola H, Lassila R, Kaukonen J, Joukov V et al. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 1998; 80: 171-175.
28. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 2004; 94: 664-670.
29. Weis S, Cui J, Barnes L, Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 2004; 167: 223-229.
30. Aguilar B, Choi I, Choi D, Chung HK, Lee S, Yoo J et al. Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor. Cancer Res 2012; 72: 5833-5842.
31. Min JK, Cho YL, Choi JH, Kim Y, Kim JH, Yu YS et al. Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice. Blood 2007; 109: 1495-1502.
32. Maeng YS, Choi HJ, Kwon JY, Park YW, Choi KS, Min JK et al. Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLCbeta2 axis. Blood 2009; 113: 233-243.
33. Bruyere F, Melen-Lamalle L, Blacher S, Roland G, Thiry M, Moons L et al. Modeling lymphangiogenesis in a three-dimensional culture system. Nat Methods 2008; 5: 431-437.
34. Paterson AD, Parton RG, Ferguson C, Stow JL, Yap AS. Characterization of E-cadherin endocytosis in isolated MCF-7 and chinese hamster ovary cells: the initial fate of unbound E-cadherin. J Biol Chem 2003; 278: 21050-21057.
35. Boensch C, Huang SS, Connolly DT, Huang JS. Cell surface retention sequence binding protein-1 interacts with the v-sis gene product and platelet-derived growth factor beta-type receptor in simian sarcoma virus-transformed cells. J Biol Chem 1999; 274: 10582-10589.